Exelixis
EXELExelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Exelixis
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 11/25/2025 | Buy | Johnson, David Edward | Director | $43.1 | $1,187,235 |
| 11/21/2025 | Sell | Haley, Patrick J. | EVP, Commercial | $42.6 | $1,194,071 |
| 11/20/2025 | Sell | Haley, Patrick J. | EVP, Commercial | $41.9 | $1,852,857 |
| 11/12/2025 | Sell | Papadopoulos, Stelios | Director | $43.6 | $4,355,000 |
| 11/11/2025 | Sell | Beckerle, Mary C. | Director | $42.0 | $1,032,414 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)